Major study shows addition of widely used agent to treatment can
prevent 50,000 heart attacks and deaths in Canada
(NC)—Cardiovascular disease remains the leading killer in
Canada. In fact, one in five of all deaths each year are from
coronary artery disease, the most common manifestation of heart
disease. Despite medical advances, far too many men and women
continue to die prematurely from this deadly disease. Many
people may know they have coronary disease yet feel quite well
until suddenly they are struck down by a heart attack. New
treatment strategies are badly needed.
Common heart pill enhances survival hopes
An important international heart study published in the prestigious medical
journal The Lancet, showed that patients with coronary artery disease who add
the safe and inexpensive blood pressure drug perindopril (Coversyl�) to their
existing treatment can significantly reduce their risk of heart attacks and
heart related deaths. In fact, perindopril (Coversyl�) reduced the risk of heart
attacks and death by 20 per cent even in patients considered relatively low
risk. "This is a major step forward and will have important implications in the
future management of coronary disease" said Dr. Jean-Claude Tardif, Director of
Clinical Research, Associate Professor of Medicine, Montreal Heart Institute.
"For the first time we have a drug that not only treats hypertension (high blood
pressure), but also improves the outcome of patients with coronary disease."
Researchers estimated that the addition of perindopril could prevent 50,000
heart attacks and deaths in Canada over the next four years. The doctors
concluded that, "treatment with perindopril, on top of other preventive
medications should be considered in all patients with coronary heart disease."
For more information, talk to your doctor or visit www.europa-trial.org.
- News Canada
About the author: